SK
Sunita Kumari
About Sunita Kumari
Data last updated:
Sunita Kumari is a Director at Genem Biotech Private Limited (since 2020) and Director at Diagnopath Life Sciences Private Limited (since 2022). The companies operate in Life Sciences and Healthcare. The largest current company by reported revenue is Genem Biotech Private Limited at ₹51.5 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Genem Biotech Private Limited U33127BR2020PTC046306 | Director | 11 Jun 2020 | 2020 | ₹51.5 Lakh (FY 2025) | Active |
 Diagnopath Life Sciences Private Limited U33100UP2022PTC169835 | Director | 29 Aug 2022 | 2022 | Active |
Board colleagues of Sunita Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Mukesh Kumar | 08759643 | Genem Biotech Private Limited | Director |
| Kanchan Panday | 09720351 | Diagnopath Life Sciences Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunita Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunita Kumari
Sunita Kumari currently holds 2 directorships: Genem Biotech Private Limited (Director, since 11 Jun 2020, revenue ₹51.5 Lakh (FY 2025)); Diagnopath Life Sciences Private Limited (Director, since 29 Aug 2022).
Sunita Kumari was first appointed on 11 Jun 2020 as Director at Genem Biotech Private Limited. The most recent appointment on record is 29 Aug 2022 at Diagnopath Life Sciences Private Limited.
The current boards of Sunita Kumari's companies include Mukesh Kumar (Genem Biotech Private Limited), Kanchan Panday (Diagnopath Life Sciences Private Limited).